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Erythrocyte deformabilityFormation of tubulin/Na+,K+-ATPase (NKA) complex in erythrocytes of hypertensive subjects results
in a 50% reduction in NKA activity. We demonstrate here that detyrosinated tubulin, which is
increased in hypertensive erythrocytes membranes, enhances the inhibitory effect of acetylated
tubulin on NKA activity. Moreover, we report a reduced content and activity of the enzyme tubulin
tyrosine ligase in erythrocytes of hypertensive subjects. Such alterations are related to changes in
erythrocyte deformability. Our ﬁndings indicate that the detyrosination/tyrosination cycle of tubu-
lin is important in regulation of NKA activity, and that abnormalities in this cycle are involved in
hypertension development.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Tubulin is biosynthesized with a tyrosine residue at the carboxy
terminus of its a-chain, and then is called tyrosinated tubulin (Tyr-
tubulin) [1]. After tubulin is polymerized into microtubules, a
tubulin tyrosine carboxypeptidase (TTCP) removes the carboxy-
terminal tyrosine to produce detyrosinated tubulin, which is also
known as Glu-tubulin because glutamic acid becomes exposed as
the carboxy-terminal amino acid [2,3]. Following depolymeriza-
tion from microtubules, detyrosinated tubulin can be tyrosinated
again through the action of tubulin tyrosine ligase (TTL), and so
the cycle continues [4,5]. Balance between the two isotypes
involved in this cycle is essential for normal cell development.Abnormalities in detyrosinated tubulin levels have been implicated
in various pathologies, including hypertension and tumor progres-
sion [6–8].
We reported recently that tubulin is found in three fractions
(membrane, cytoplasmic and sedimentable fraction) of human
erythrocytes [6] and formation of an Ac-tubulin complex with
Na+,K+-ATPase (NKA) in the membrane [6] could be responsible
of lower NKA activity in erythrocytes from hypertensive subjects
observed by other groups [9,10].
We demonstrated previously that tubulin must be in acetylated
form to interact with NKA [11]. However, no studies to date have
examined the possible roles of other post-translational modiﬁca-
tions of tubulin, particularly detyrosination, in the regulatory
mechanism mentioned above. Based on our ﬁnding of increased
detyrosinated tubulin levels in hypertensive erythrocyte mem-
branes [6], we hypothesized that the detyrosinated tubulin isotype,
in addition to Ac-tubulin, is involved in the regulation of NKA
activity. The results of the present study demonstrate that:
(i) although acetylation of tubulin is essential for complex formation
with NKA, detyrosinated tubulin appears to play an important role
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sinated tubulin in hypertensive erythrocytes is due to decreased
content and activity of TTL but not TTCP; (iii) membrane levels of
detyrosinated tubulin are related to NKA activity and erythrocyte
deformability, which are reduced in hypertensive subjects [12,13].
In view of these results, we propose that the reduced TTL activ-
ity in hypertensive erythrocyte membranes is responsible for
increased levels of detyrosinated tubulin, which causes inhibition
of NKA activity and erythrocyte deformability, and that both
effects are closely related to the development of arterial
hypertension.
2. Materials and methods
2.1. Materials
Nitrocellulose membrane, nocodazole, parthenolide, DMSO,
carboxypeptidase pancreatic A bovine, PMSF, Triton X-100, SDS,
pyruvate kinase, lactate dehydrogenase, phosphoenolpyruvate,
ATP, NADH, and Tween were obtained from Sigma–Aldrich (St.
Louis, MO, USA). Lumigen™ PS-3 detection kit and high-
performance chemiluminescence ﬁlm were from GE Healthcare
Life Sciences (Piscataway, NJ, USA).
2.2. Antibodies
Mouse anti-Ac-tubulin mAb 6-11B-1, mouse anti-a-tubulin
mAb DM1A, anti-Tyr-tubulin mAb Tub1-A2, peroxidase-conju-
gated mouse or rabbit IgG, and ﬂuorescein-conjugated mouse
IgG were from Sigma. Rabbit polyclonal Ab H-300 speciﬁc to
a-subunit of NKA was from Santa Cruz Biotechnology. Rabbit
anti-TTL polyclonal Ab ID3 was kindly provided by
Dr. J. Wehland (Max Planck Institute for Biophysical Chemistry,
Goettingen, Federal Republic of Germany). Rabbit anti-
detyrosinated tubulin polyclonal Ab was prepared as described
by Gundersen et al. [14].
2.3. Human subjects and erythrocyte preparation
Patients at the Hospital Regional de Río Cuarto (Argentina) were
recruited for this study. All procedures were performed in compli-
ance with relevant laws and institutional guidelines and using an
informed and written consent protocol approved by the Commit-
tee on Research Ethics (CoEdi) of the Universidad Nacional de Río
Cuarto, which are in accord with the standards set by the Declara-
tion of Helsinki. Demographic and hemodynamic data of the
patients are shown in Table 1. Fresh blood samples were collected
using 3.4 mM EDTA as an anticoagulant and stored for 96 h at 4 C.Table 1
Demographic and hemodynamic data of the studied population.
Parameters H (n = 35) N (n = 20) P
Age (years) 43 ± 11 39 ± 14 –
Sex, male/female 22/13 11/9
Weight (kg) 86 ± 17 79 ± 12 NS
Systolic BP (mmHg) 167 ± 18 121 ± 11 <0.05
Diastolic BP (mmHg) 109 ± 10 73 ± 7 <0.05
Triglycerides (mg/dl) 268 ± 13 103 ± 8 <0.01
Diabetes (yes/no) 0/35 0/20 –
Hypercholesterolemia (yes/no) 3/32 0/20 –
Antihypertensive treatment (yes/no) 19/16 – –
Urea (mg/dl) 33 ± 7 34 ± 8 NS
Creatinine (mg/dl) 0.75 ± 0.13 0.71 ± 0.14 NS
Na+ (mM) 141 ± 13 144 ± 10 NS
K+ (mM) 5 ± 1 4 ± 2 NS
H hypertensive patients, N normotensive patients, NS not signiﬁcant.Blood sample pooling was always omitted. Individual blood sam-
ples were incubated (when required) with 50 lM nocodazole for
1 h at 37 C or with 20 lM parthenolide for 2 h at 37 C. In other
experiments, erythrocytes were treated with 30 mM glucose in
the presence or absence of 0.5 mM tyrosine for 2 h at 37 C. In
experiments where hypertensive blood samples were used, blood
samples of patients with and without anti-hypertensive treatment
were used. Following treatment, erythrocytes were isolated by
conventional centrifugal separation and used immediately. Hyper-
tensive subjects were selected based on a history of blood pressure
consistently > 160/110 mmHg.
2.4. Blood pressure measurement
Blood pressure was measured using a mercury sphygmoma-
nometer after 10 min of rest in the seated position, 20–30 min after
obtaining blood samples in the opposite arm to that subjected to
venesection. Five consecutive BP readings were obtained using an
appropriately sized cuff, 30–60 s apart. The average of the 5 read-
ings was taken as the BP.
2.5. Isolation of cytosolic and membrane fractions from human
erythrocytes
Different fractions of human erythrocytes were isolated follow-
ing the method described by Amaiden et al. [6]. Brieﬂy, erythro-
cytes isolated from 2 ml human blood were resuspended in 3 ml
lysis buffer (7.5 mM sodium phosphate buffer, pH 7.5, containing
1 mM EDTA and 20 lg/ml PMSF) and incubated for 15 min in ice-
water. The lysate was centrifuged (20000g) for 20 min at 4 C.
The pellet was washed three times with 6 ml lysis buffer without
PMSF, resuspended in 0.3 ml lysis buffer (membrane fraction),
and stored at 20 C until use, except when membranes were used
as NKA source, in this case, they were used immediately. The
supernatant fraction from the 20000g centrifugation was imme-
diately centrifuged at 100000g for 30 min at 30 C. The superna-
tant, containing cytosolic fraction, was passed through a Sephadex
G-25 column pre-equilibrated with sodium phosphate buffer for
TTL activity determination.
2.6. Animals
Male Wistar rats were housed (ﬁve per cage) under controlled
temperature and humidity, with a cycle of 12 h light/12 h dark,
and food and water ad libitum. All experimental protocols followed
the guidelines of the Committee on Research Ethics (CoEdi) of the
Universidad Nacional de Río Cuarto regarding the care and use of
laboratory animals, minimization of suffering, and the number of
animals used. Rats were maintained without treatment. Rats of
30- to 60-days-old were sacriﬁced and brains were removed to
obtain membranes and tubulin. Rats were sacriﬁced by decapita-
tion without anesthesia avoiding animal suffering.
2.7. Rat brain membranes
Rat brain membranes were obtained according to [15]. Brains
from 30- to 60-day-old Wistar rats were homogenized at 4 C in
5 volumes of Tris-sucrose buffer (10 mM Tris, pH 7.4, containing
0.24 M sucrose) and centrifuged at 1000g for 5 min. The pellet
was discarded, and the supernatant was centrifuged at 16000g
for 20 min at 4 C. The pellet was washed twice with Tris-sucrose
buffer and resuspended in water (3 ml per g of original tissue).
The suspension was stirred for 30 min in ice-cold water and centri-
fuged at 16000g for 20 min. The pellet was resuspended in TBS
(1 ml per g of original tissue), and the suspension was used
immediately.
Fig. 1. Effect of detyrosinated tubulin on NKA activity. (A) Equal quantities of total
tubulin were used for quantiﬁcation of acetylated and detyrosinated tubulin by
immunoblotting. Three experiments were performed, and regions containing
relevant bands from a representative experiment are shown. (B) NKA activity was
measured by the NADH oxidation method. Prior to ATP addition, the mixture was
preincubated for 25 min at 37 C with two tubulin preparations: (i) low detyrosi-
nated tubulin content (‘‘Low’’; j); (ii) high detyrosinated tubulin content (‘‘High’’;
h). The ‘‘High’’ preparation was obtained by incubation of tubulin with 10 lg/ml
bovine carboxypeptidase for 40 min at 37 C. The data are expressed as a
percentage of control value; mean ± S.D. from three independent experiments.
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Brains from 30- to 60-day-old rats were homogenized at 4 C in
1 volume of MEM buffer containing 1 mM MgCl2. The homogenate
was centrifuged at 100000g for 45 min, and the pellet was dis-
carded. Tubulin was puriﬁed by two cycles of assembly/disassem-
bly followed by phosphocellulose chromatography. Purity and
quality of tubulin was evaluated by SDS–PAGE and Coomassie Blue
R250 staining (only one 55 KDa protein band in the gel was seen)
and its ability to polymerize in microtubules (with GTP and taxol),
respectively [15,16]. To obtain tubulin with a high content of the
detyrosinated isotype, MAP-free tubulin was incubated for
40 min at 37 C with 10 lg/ml bovine carboxypeptidase pancreatic
A (CPA) as described by Barra et al. [17], and the preparation was
kept on ice until use. Tubulin without CPA treatment was used as
tubulin with low content of the detyrosinated isotype.
2.9. Incorporation of [14C]tyrosine into tubulin
[14C]Tyrosine was incorporated into tubulin as described by
Alonso et al. [18]. In brief, the incubation medium contained, per
ml, 0.9 ml rat brain extract (passed previously through a Sephadex
G-25 column equilibrated with 10 mM sodium phosphate buffer,
pH 7), 2.5 lmol ATP, 100 lmol KCl, 10 lmol MgC12, and 0.32 lmol
(3 lCi) [14C]tyrosine. The mixture was incubated at 37 C for
30 min, passed again through the Sephadex G-25 column, mea-
sured for radioactivity bound to protein, and stored at 4 C until
use.
2.10. Determination of TTL activity in human erythrocytes
A cytosolic fraction of erythrocytes (300 ll) and 500 lg unla-
beled three-cycle microtubule protein from rat brain were added
to the reaction mixture (2.5 mM ATP, 100 mM KCl, 12.5 mMMgCl2,
and 0.32 mM (0.75 lCi) [14C]tyrosine) and incubated at 37 C. After
5 min of incubation, a 100-ll aliquot of the mixture was inacti-
vated by addition of 20% trichloroacetic acid (100 ll). The mixtures
were heated at 90 C for 20 min, tubes were centrifuged at
10000g for 30 min, and radioactivity incorporated into tubulin
was measured by ﬁltration through DE81 disc ﬁlter paper as
described for [3H]colchicine binding [19]. In control tubes, buffer
solution was used instead of erythrocyte cytosolic fraction.
2.11. Determination of tubulin tyrosine carboxypeptidase activity
Determination of TTCP was done according [20]. The incubation
system for this assay contained 0.3 ml erythrocyte cytosolic fraction
and 100 ll (50 lg, 15000 cpm) [14C]tyrosinated tubulin puriﬁed
from rat brain and pre-incubated at 37 C in the presence of 1 mM
GTP and 10% glycerol for microtubule formation. The mixture was
incubated at 37 C for 30 min, inactivated by addition of 20% trichlo-
roacetic acid (0.1 ml), and centrifugedat 10000g for 30 minat 4 C.
Radioactivity was measured in an 80-ll aliquot of the supernatant
fraction. Radioactivity released during incubation without tubulin
tyrosine carboxypeptidase was subtracted from experimental val-
ues. Released [14C]tyrosine was expressed as pmol of tyrosine
released per mg protein in the erythrocyte cytosolic fraction.
2.12. Immunoﬂuorescence microscopy
Erythrocytes were stained by indirect immunoﬂuorescence as
described by DeWitt et al. [21]. The primary antibodies used were
mAb DM1A (dilution 1:1000), mAb Tub-1A2 (dilution 1:1000), or
polyclonal anti-Glu-tubulin (dilution 1:200) to visualize tubulin,
or polyclonal ID3 (dilution 1:100) to visualize TTL. The secondary
antibody was ﬂuorescein-conjugated anti-rabbit IgG (dilution1:50) or anti-mouse IgG (dilution 1:50). Coverslips were mounted
in Fluor-Save and observed with a ﬂuorescence microscope (Nikon,
Eclipse 50i). As we demonstrated previously [6], a uniform distri-
bution of ﬂuorescence in erythrocytes indicates a high content of
Mem-tub, whereas a ﬂuorescent ring pattern indicates a tubulin
localization at the sedimentable fraction.
2.13. Immunoblotting
Proteins were separated by SDS–PAGE on 12% polyacrylamide
slab gel by the method of Laemmli [22], and the gel was transferred
to a nitrocellulose sheet. Blots were reacted with mAb DM1A (dilu-
tion 1:1000), 6-11B-1 (dilution 1:1000), ID3 (dilution 1:1000), or
anti-Glu-tubulin (dilution 1:200). The sheet was reacted with the
corresponding peroxidase-conjugated anti-IgG antibody and
stained by the 4-chloro-1-naphtholmethod or the ECL system. Band
intensities were quantiﬁed by the Scion Image software program.
2.14. NKA activity assay
NKA enzyme activity was determined by the method of
Salvador and Mata [23]. Erythrocyte membranes (5–10 lg protein)
Fig. 2. Parthenolide effect on NKA activity. Hypertensive (H) and normotensive (N)
human erythrocytes were treated with 50 lM nocodazole for 1 h at 37 C. The
nocodazole was then removed, and the samples were resuspended in plasma with
(+) or without () 20 lM parthenolide. The erythrocytes were lysed, and a
membrane fraction was obtained. (A) Membranes were used to determine total,
acetylated and detyrosinated tubulin by immunoblotting. A loading control was
performed for NKA using rabbit polyclonal H-300 antibody. Three experiments
were performed, and regions containing relevant bands from a representative
experiment are shown. The values (mean ± S.D. from three independent experi-
ments) shown below the blot represents quantiﬁcation of tubulin bands by
densitometry using Scion Image software. (B) NKA activity was measured by the
NADH oxidation method. The data are expressed as a percentage of control value;
mean ± S.D. from three independent experiments.
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20 mM KCl, 100 mM NaCl, 2.5 mM MgCl2, 0.5 mM EGTA,
0.16 mM NADH, 1 mM phosphoenolpyruvate, 2.5 IU pyruvate
kinase, 2.5 IU lactate dehydrogenase) in a ﬁnal volume of 340 ll.
The mixture was kept for 10 min at room temperature, and the
reaction was initiated by addition of 1 mM ATP. NADH oxidation
was measured for 15 min at room temperature using a recording
spectrophotometer at wavelength 340 nm. Control cuvettes were
prepared without enzyme or with heat-denatured enzyme.
Enzyme activity was estimated as the difference between samples
incubated in the absence vs. presence of 1 mM ouabain.
2.15. Determination of erythrocyte deformability
Erythrocyte deformability was determined using the ﬁltration
method described by Cabrales [24]. In brief, polycarbonate ﬁlters
(Nuclepore/Whatman; Pleasanton, CA, USA) with pore size 5 lm,
diameter 13 mm, and pore density 4  103/mm2 were perfused
with diluted cell suspensions using an infusion pump. Cell suspen-
sions or medium (buffer) were delivered through the ﬁlter at a rate
of 1.1, 1.2, 1.3, 1.4, or 1.5 ml/min. The pressure drop across the
ﬁlter was measured with a differential pressure transducer.
Erythrocyte deformability was assessed by determining theparameters b and w. b is the ratio of the resistance to ﬂow through
a ﬁlter pore calculated according to the equation:
b ¼ ðPi=Po 1Þt=hþ 1
where Pi is pressure drop across the ﬁlter, Po is the pressure drop in
the presence of cells, t is the ratio of mean cell volume to pore vol-
ume, and h is the volume of packed erythrocyte fraction of the per-
fusate. Filtration measurements were performed in triplicate at a
hematocrit of 0.12, using different ﬁlters, and averaged. b is depen-
dent on the ﬂow used to deform the cells, whilew is the slope of the
curve b vs. ﬂow. An increase in w reﬂects a decrease in erythrocyte
deformability and is independent of the ﬂow used to deform the
cells.
2.16. Protein determination
Protein concentration was determined by the method of Brad-
ford [25].
2.17. Statistical analysis
Results were expressed as mean ± SD. Student’s t-test was used
for the comparison of means between two groups. Differences in
means were considered statistically signiﬁcant for P < 0.05.3. Results
3.1. Detyrosinated tubulin enhanced the inhibitory effect of Ac-tubulin
on NKA activity
In hypertensive erythrocyte membranes, detyrosinated tubulin
is the isotype showing the greatest increase [6], we therefore
tested the possibility that detyrosination is involved in NKA regu-
lation by measuring enzyme activity in rat brain membranes trea-
ted with two tubulin preparations that contained similar levels of
total tubulin and Ac-tubulin but different levels of detyrosinated
tubulin. The preparation pre-treated with bovine carboxypeptidase
produced a 5-fold increase in detyrosinated tubulin content
(Fig. 1A). Both tubulin preparations reduced NKA activity in a
dose-dependent manner (Fig. 1B). However, for the preparation
containing a higher proportion of detyrosinated tubulin, a concen-
tration of 50 lg tubulin/ml was sufﬁcient to produce a 50% inhibi-
tion of NKA activity and maximal inhibition (90%) was achieved
with a concentration of 150 lg tubulin/ml. In contrast, for the
preparation that had low detyrosinated tubulin content a concen-
tration of 200 lg tubulin/ml was necessary to reach 50% NKA activ-
ity inhibition, and maximal inhibition was achieved with a
concentration of 300 lg tubulin/ml (2-fold higher than for the ﬁrst
preparation). An incubation system of carboxypeptidase without
tubulin was used as a control; this preparation had no effect on
NKA activity (data not shown). These ﬁndings suggest that while
acetylation is essential for tubulin/NKA interaction [11,15], detyro-
sination of tubulin enhances the inhibitory effect of Ac-tubulin on
NKA activity.
To test this hypothesis, we conducted two experiments in which
NKA activity of human erythrocytes was assayed in the presence of
compounds that modify detyrosinated tubulin content. Partheno-
lide, which efﬁciently inhibits TTCP [26], was used in the ﬁrst
experiment (Fig. 2). Erythrocytes were treated with 20 lM parthe-
nolide and detyrosinated, and Ac-tubulin content and NKA activity
in the membrane were determined. The erythrocytes were incu-
bated with nocodazole prior to parthenolide treatment to deplete
membrane tubulin [6] and remove all tubulin associated with
NKA. After the nocodazole was washed out, the cells were incu-
bated with parthenolide (+parthenolide) for 2 h at 37 C; during
Fig. 3. Effect of glucose/tyrosine on membrane detyrosinated tubulin and NKA activity. Human erythrocytes were treated with physiological solution (control), 30 mM
glucose (+glucose) or 30 mM glucose and 0.5 mM tyrosine (+glucose + tyrosine) for 2 h at 37 C. Following treatment, erythrocytes were washed twice and suspended in
physiological solution. (A) Erythrocytes from each treatment were subjected to visualization of total tubulin and detyrosinated tubulin (Glu-tub) by immunoﬂuorescence
using speciﬁc antibodies as described in Section 2. (B) Fluorescence intensity for each cell were quantiﬁed using Scion Image software, values shown (mean ± S.D.) are an
average of at least 30 cells by experiment from three independent experiments and were expressed as arbitrary units (AU). NKA activity was determined by the NADH
oxidation method in membrane fractions. The data are expressed as pmol/min/mg protein; mean ± S.D. from three independent experiments.
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membranes. As a control, erythrocytes were incubated under the
same conditions but without parthenolide (parthenolide). In the
+parthenolide normotensive erythrocytes cells, detyrosinated
tubulin levels in membranes were greatly reduced (50%), whereas
levels of total tubulin and Ac-tubulin were unchanged (Fig. 2A).
NKA activity was increased 90% in the +parthenolide cells
(Fig. 2B). With hypertensive erythrocytes, parthenolide treatment
did not cause signiﬁcant changes of membrane levels of detyrosi-
nated tubulin, Ac-tubulin, or NKA activity (Fig. 2).
In the second experiment, erythrocytes were treated with high
glucose concentration (Fig. 3), which induces increased membrane
tubulin content and consequent inhibition of NKA activity in
human erythrocytes [27]. As we demonstrated previously, a uni-
form distribution of ﬂuorescence in erythrocytes indicates a high
content of Mem-tub, whereas a ring pattern of ﬂuorescence indi-
cates a low Mem-tub content [28]. The total content of the detyro-
sinated tubulin isotype was not signiﬁcantly altered by glucose
treatment (Fig. 3B), however, distribution was affected; in non-
treated erythrocytes (control) ﬂuorescence was seen as a thin
peripheral ﬂuorescence ring, indicating that detyrosinated tubulin
was located in sedimentable fraction, whereas after glucose treat-
ment, ﬂuorescence is distributed through the entire cell, indicating
a high tubulin content in the plasma membrane tubulin. Typical
ﬂuorescence signal for each fraction was previously determined
by our group [6,28]. Then results suggest that detyrosinated tubu-
lin was translocated to the membrane fraction following glucose
treatment (Fig. 3A). A similar effect was observed for a-tubulin.
Consistently with the above ﬁndings, glucose treatment
induced a signiﬁcant reduction of NKA activity (Fig. 3B), suggesting
that increased detyrosinated tubulin in the membrane is involvedin NKA inhibition. If so, reducing detyrosinated tubulin content fol-
lowing glucose treatment should restore NKA activity. We tested
the possibility that tyrosine reverses the effect of glucose on NKA
activity. The presence of tyrosine caused a 50% reduction of dety-
rosinated tubulin content, and NKA activity was not signiﬁcantly
affected by glucose treatment (Fig. 3B). The distribution of detyro-
sinated tubulin was also modiﬁed under this condition and the
translocation induced by glucose was partially inhibited; some
detyrosinated tubulin was still observed in the membrane fraction,
but it was also observed (intense ﬂuorescence) in the sedimentable
fraction. Taken together, the results from experiments with parthe-
nolide, glucose, and tyrosine conﬁrm that detyrosinated tubulin
levels are involved in the regulation of NKA activity in human
erythrocytes.
3.2. High detyrosinated tubulin content in hypertensive erythrocytes is
correlated with low TTL expression
Our previous study showed that the proportion of detyrosinated
tubulin is elevated in hypertensive erythrocyte membranes [6].
Similarly, in the present study, total tubulin content was similar
in normotensive vs. hypertensive erythrocytes, but the distribution
was altered in the latter group; tubulin was translocated from the
sedimentable fraction to the membrane fraction (Fig. 4A). The dis-
tributions of the detyrosinated and tyrosinated tubulin isotypes
were modiﬁed similarly to that of total tubulin: the levels of both
isotypes were reduced in the sedimentable fraction and increased
in the membrane fraction. In contrast to total tubulin, the levels of
the detyrosinated and tyrosinated isotypes were modiﬁed in
hypertensive erythrocytes: detyrosinated tubulin was increased
50% and tyrosinated tubulin was reduced by 40%.
Fig. 4. Detyrosinated tubulin content and TTL and TTCP activities in hypertensive erythrocytes. (A) Normotensive (N) and hypertensive (H) human erythrocytes were
subjected to visualization of total tubulin, tyrosinated (Tyr) and detyrosinated (Glu) tubulin by immunoﬂuorescence using speciﬁc antibodies as described in Section 2.
Fluorescence intensity for each cell were quantiﬁed using Scion Image software, values shown (mean ± S.D.) are an average of at least 30 cells by experiment from three
independent experiments and were expressed as arbitrary units (AU). (B) Products of incorporation of [14C]tyrosine into exogenous tubulin were subjected to
immunoﬂuorescence with mAb DM1A on nitrocellulose sheets. Each fraction was used to determine radioactivity. (C) TTL and TTPC activities were determined in cytosolic
fractions of hypertensive or normotensive erythrocytes as described in Section 2. The values (mean ± S.D.) from ﬁve independent experiments were expressed as pmol/min/
mg protein.
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ties of TTCP and TTL in hypertensive and normotensive erythro-
cytes. TTL activity was assayed by measuring incorporation of[14C]tyrosine into exogenous tubulin. An aliquot of the incubation
products was subjected to SDS–PAGE, and the gel was stained with
Coomassie Brilliant Blue. Over 95% of the protein was found in a
Fig. 5. TTL content in hypertensive human erythrocytes. (A) Cytosolic fractions of
hypertensive (H) or normotensive (N) human erythrocytes were obtained and used
to determine TTL content by immunoblotting using polyclonal anti-TTL antibody
ID3 and ECL system to stain. The same western was probed with DM1A to
quantiﬁed tubulin as loading control, using 4-chloro-1-naphthol staining method.
Three experiments were performed, and regions containing relevant bands from a
representative experiment are shown. (B) Bands were quantiﬁed using Scion Image
software, and values are shown. The data are expressed as arbitrary units;
mean ± S.D. from three independent experiments. (C) Hypertensive and normoten-
sive erythrocytes were ﬁxed on coverslips and analyzed by immunoﬂuorescence
microscopy (left panel) using ID3, as described in Section 2. Inner ﬂuorescence
through the erythrocyte was measured using Scion Image software, and values of a
representative cell of at least 30 cells are shown in the right panel. F.I., ﬂuorescence
intensity. E.D., erythrocyte diameter.
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almost all of the radioactivity (Fig. 4B). The incorporation of radio-
activity into tubulin indicates the presence of TTL in cytosolic frac-
tions of human erythrocytes. TTL from both groups was able to
incorporate [14C]tyrosine; however, the activity was 0.06 pmol/
min/mg protein in normotensive erythrocytes and 0.034 pmol/
min/mg protein (43% lower) in hypertensive erythrocytes. These
ﬁndings suggest that the increased detyrosinated tubulin level in
hypertensive erythrocytes results from reduced TTL activity.The observed decrease in TTL activity did not rule out the pos-
sibility that the increased detyrosinated tubulin level in hyperten-
sive erythrocytes also involved a modiﬁcation of TTCP activity. We
therefore measured TTCP activity in extracts of normotensive and
hypertensive erythrocytes. Both extracts contained measurable
TTCP activity. However, in contrast to the results for TTL activity,
no signiﬁcant difference was observed between normotensive
and hypertensive erythrocytes (Fig. 4C). This ﬁnding suggests that
the increased detyrosinated tubulin level in hypertensive erythro-
cytes is due to reduced TTL activity but not to increased TTCP
activity.
To determine whether the reduced TTL activity in hypertensive
erythrocytes was correlated with changes in TTL content, we iso-
lated cytosolic fractions of normotensive and hypertensive eryth-
rocytes and analyzed TTL content by immunoblotting. Visual
examination of bands revealed a markedly lower TTL content in
hypertensive erythrocytes for all protein concentrations analyzed
(Fig. 5A). Quantiﬁcation of bands showed that TTL content was
50% lower in hypertensive than in normotensive erythrocytes
(Fig. 5B). TTL content in erythrocytes was further evaluated by
immunoﬂuorescence microscopy. In normotensive erythrocytes
treated with anti-TTL Ab ID3, ﬂuorescence corresponding to TTL
was dispersed in the cytoplasm, whereas ID3-treated hypertensive
erythrocytes displayed a relatively bright zone at the periphery,
beneath the membrane (Fig. 5C). This distribution was conﬁrmed
by quantiﬁcation of ﬂuorescence along the erythrocyte diameter.
These ﬁndings indicate that hypertensive erythrocytes have a
different localization of TTL as well as lower TTL content in
comparison with normotensive erythrocytes.
3.3. The increased level of detyrosinated tubulin in human
erythrocytes results in modiﬁcation of deformability
Since previous studies showed that modiﬁcation of NKA activity
is related to changes in erythrocyte deformability [29–31], a rheo-
logical property which is closely associated with the development
of hypertension [12,13,28]. We therefore analyzed the effect of
treatment with parthenolide or glucose/tyrosine on deformability.
In parthenolide-treated normotensive erythrocytes, b and w
values were reduced by 40% (Fig. 6A and C), indicating decreased
ﬂow resistance and increased deformability. These results are con-
sistent with the decreased membrane detyrosinated tubulin con-
tent and increased inhibition of NKA activity by TTCP in
parthenolide-treated cells (Fig. 2). No signiﬁcant change of w value
by parthenolide treatment was observed in hypertensive erythro-
cytes, consistent with the lack of effect of parthenolide on mem-
brane detyrosinated tubulin level or NKA activity in these cells
(Fig. 2).
In normotensive erythrocytes treated with glucose/tyrosine,
correlations were observed among membrane detyrosinated tubu-
lin level, NKA activity, and cell deformability. Glucose, which we
showed to increase membrane detyrosinated level (Fig. 2), induced
a 60% increase of w and a consequent decrease of deformability
(Fig. 6B and C). However, the co-presence of tyrosine reversed
the effect of glucose; i.e., w values were not signiﬁcantly different
from control values under this condition (Fig. 6B and C). These
ﬁndings, taken together, reveal an inverse correlation between
membrane detyrosinated tubulin content and erythrocyte
deformability.
Due to there is a signiﬁcantly increase of triglycerides content
in the blood of hypertensive subjects, we cannot discard the
involvement of these lipids on the observed phenomena; how-
ever, treatment of erythrocyte from normotensive subjects with
glucose or parthenolide showed changes in deformability and
NKA activity in response to modiﬁcations of levels of detyrosinat-
ed tubulin in samples with similar content of triglycerides,
Fig. 6. Effect of membrane detyrosinated tubulin on deformability of human erythrocytes. (A) A sample of human blood (2 ml) from normotensive (N) or hypertensive (H)
subjects was incubated for 2 h at 37 C in the absence or presence of 50 lM parthenolide (+Part). Aliquots (1 ml) of blood from each treatment were washed, resuspended in
physiological solution (the original volume was maintained), and used for determination of ﬂow resistance (b) and deformability (w) as described in Section 2. (B) An aliquot
(1 ml) of blood from normotensive subjects was treated with 30 mM glucose in the absence (Glu) or presence of 0.5 mM tyrosine (Glu + Tyr), and b and w values were
measured as in (A). (C) Values for deformability (w) from each treatment were calculated from the slope of the respective curve. The % of control (Cn) values were calculated
relative to w values from N and H without treatment deﬁned as 100%. The values shown are mean ± S.D. from three independent experiments.
Fig. 7. Proposed mechanism (schematic) of NKA regulation and cell deformability by tubulin in erythrocytes. In hypertensive erythrocytes, decreases in TTL content and
activity induce increased detyrosinated tubulin levels in the sedimentable fraction and consequent translocation to the plasma membrane. In the membrane, Ac-tubulin
forms a complex with NKA and inhibits its enzymatic activity, and erythrocyte deformability is consequently reduced. In normotensive subjects, an appropriate equilibrium
in the detyrosination/tyrosination cycle prevents excessive accumulation of membrane tubulin and promotes correct NKA function and cell deformability.
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triglycerides content.
4. Discussion
Post-translational modiﬁcations of tubulin have an important
role as temporal or spatial markers of microtubules indicating
binding sites of proteins that regulate a variety of cellular events
[32]. In the present study, we demonstrate in vitro that although
acetylation is essential to tubulin form a complex with NKA
[11,25], an increased level of detyrosinated tubulin is able to
inhibit NKA activity.
The effect of detyrosinated tubulin was studied further in whole
erythrocytes treated with parthenolide or glucose/tyrosine.
Parthenolide treatment of human erythrocytes reduced membranedetyrosinated tubulin level and signiﬁcantly increased NKA activ-
ity. Glucose treatment had the opposite effect; i.e., increased dety-
rosinated tubulin level and reduced NKA activity. Co-treatment
with tyrosine reversed the effect of glucose. Although acetylation
of tubulin is essential for complex formation with NKA, results
shown that the tyrosination/detyrosination status of tubulin
appears to play an important role in regulation of NKA activity.
We do not know if detyrosination and acetylation occurs in the
same chain, it would be an interesting point to future study. Use
of CAD cells could be an helpful tool to elucidate this question, since
in these cells acetylated tubulin are absent but levels of this isotype
of tubulin appears after treatment of cells with trichostatin A [11].
NKA function generates transmembrane chemical and electrical
gradients that are essential for excitation activity of muscle and
nerve tissue, as well as the regulation of cell volume and a number
372 M.R. Amaiden et al. / FEBS Letters 589 (2015) 364–373of Na+-coupled transporters [33,34]. Because of the multiple func-
tions of NKA, alterations of its enzymatic activity are associated
with a variety of pathological conditions, including arterial hyper-
tension [35]. We demonstrated previously that detyrosinated
tubulin level is increased in hypertensive erythrocyte membranes
[6]. We now propose that this alteration is an important factor in
modiﬁcation of NKA activity. The mechanism of the increased
detyrosinated tubulin level in hypertensive erythrocytes is unclear.
The tubulin tyrosination capacity of cells depends on the equilib-
rium between two enzymes, TTCP and TTL activities [2,4]. Abnor-
malities in the cycle have been implicated in various pathological
conditions [6,8]. Our present ﬁndings indicate that the increased
detyrosinated tubulin level in hypertensive erythrocytes is a con-
sequence of reduced tubulin tyrosination capacity. Both the con-
tent and activity of TTL are reduced in hypertensive erythrocytes,
whereas the activity of TTCP is not signiﬁcantly different from
those in normotensive erythrocytes.
On other hand, we observed correlations among membrane
detyrosinated tubulin, NKA activity, and erythrocyte deformability.
Glucose, which increases detyrosinated tubulin level, caused
reductions of NKA activity and deformability. Co-treatment with
tyrosine reversed these effects. In contrast, treatment with parthe-
nolide (which inhibits TTCP and reduces detyrosinated tubulin
level) caused an increase of NKA activity and deformability in nor-
motensive erythrocytes. Parthenolide had no effect on deformabi-
lity, detyrosinated tubulin level, or NKA activity in hypertensive
erythrocytes. In view of the high reactivity and numerous targets
of parthenolide, we cannot rule out the possibility that the absence
of effect of parthenolide on hypertensive erythrocytes is an indirect
consequence of its action on some other target, e.g., regulatory
enzymes such as kinases or phosphatases [26].
The pathogenesis of essential hypertension is poorly under-
stood. However, because arterial pressure is deﬁned as the product
of cardiac output and peripheral resistance, it is clear that hemo-
rheological factors in microcirculation play a primary role. Changes
in deformability as observed in the present study may be a conse-
quence of NKA inhibition induced by alteration of detyrosinated
tubulin level. Our previous study revealed correlations among
erythrocyte membrane tubulin content, deformability, and blood
pressure [28]. This phenomena would be independent of the high
content of triglycerides observed in blood of hypertensive subjects
(Table 1), since we observed changes in deformability and NKA
activity in response to modiﬁcations of levels of detyrosinated
tubulin in samples with similar content of triglycerides
(Figs. 1–3). The present results support this concept and suggest
that the mechanism involves changes in detyrosinated tubulin
level. Moreover, considering that the changes reported in this
study are expected to occur in other cell types and due to the ubiq-
uity and functions of NKA in mammalian cells, such as in the vas-
cular wall, renal proximal tubular cells, brain, etc., these changes
could be pointed out as contributory factors in the pathogenesis
of hypertension.
Based on our previous [28] and present results, we propose the
model illustrated in Fig. 7. The reduced TTL content and activity and
increased stability of the sedimentable tubulin fraction in hyper-
tensive subjects induce increased levels of detyrosinated tubulin
and Ac-tubulin. These tubulin isotypes are translocated through
an unknownmechanism to themembrane, where Ac-tubulin forms
a complex with NKA. Detyrosinated tubulin plays an important role
in enhancing the inhibitory effect of Ac-tubulin on NKA. NKA is
involved in decreased erythrocyte deformability, an important fac-
tor in the progression of hypertension. No differences in the results
were observed between hypertensive subjects treated or not with
anti-hypertensive drugs, suggesting that the results were indepen-
dent of these treatments. In normotensive subjects, an appropriate
equilibrium in the detyrosination/tyrosination cycle preventsexcessive accumulation of membrane tubulin and promotes correct
NKA function and cell deformability. The proposed mechanism
clearly indicate an essential role of tubulin in the regulation of
the rheological properties of erythrocytes and provides important
knowledge because the regulation of this system could be promis-
ing therapeutic target for the treatment of hypertension.
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